Global Non-injectable Insulin Market Growth 2026-2032
The global Non-injectable Insulin market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Non-injectable insulin refers to a class of medications used to treat diabetes that do not need to be administered by injection. These medications are usually given orally or by other non-injectable routes to help control blood sugar levels and reduce or delay the onset of diabetes-related complications.
People with diabetes rely on insulin to control their blood glucose levels. This drug regulates and controls blood glucose levels by injected subcutaneously. A report from 2022 indicated that diabetes drugs around the world generated revenue of $78 billion. Since insulin is the preferred drug of choice for most diabetics, nasal or oral insulin intake provides comfort as an effective alternative to all other diabetes drugs.
LP Information, Inc. (LPI) ' newest research report, the ?Non-injectable Insulin Industry Forecast? looks at past sales and reviews total world Non-injectable Insulin sales in 2025, providing a comprehensive analysis by region and market sector of projected Non-injectable Insulin sales for 2026 through 2032. With Non-injectable Insulin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-injectable Insulin industry.
This Insight Report provides a comprehensive analysis of the global Non-injectable Insulin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-injectable Insulin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Non-injectable Insulin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-injectable Insulin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-injectable Insulin.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-injectable Insulin market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Non-injectable insulin refers to a class of medications used to treat diabetes that do not need to be administered by injection. These medications are usually given orally or by other non-injectable routes to help control blood sugar levels and reduce or delay the onset of diabetes-related complications.
People with diabetes rely on insulin to control their blood glucose levels. This drug regulates and controls blood glucose levels by injected subcutaneously. A report from 2022 indicated that diabetes drugs around the world generated revenue of $78 billion. Since insulin is the preferred drug of choice for most diabetics, nasal or oral insulin intake provides comfort as an effective alternative to all other diabetes drugs.
LP Information, Inc. (LPI) ' newest research report, the ?Non-injectable Insulin Industry Forecast? looks at past sales and reviews total world Non-injectable Insulin sales in 2025, providing a comprehensive analysis by region and market sector of projected Non-injectable Insulin sales for 2026 through 2032. With Non-injectable Insulin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-injectable Insulin industry.
This Insight Report provides a comprehensive analysis of the global Non-injectable Insulin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-injectable Insulin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Non-injectable Insulin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-injectable Insulin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-injectable Insulin.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-injectable Insulin market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Oral Pills
- Sprays
- Others
- T1DM
- T2DM
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novo Nordisk
- Sanofi
- Eli Lilly
- MannKind Corporation
- Biocon
- Janssen Pharmaceuticals
- Adocia
- Oramed Pharmaceuticals
- Aerami Therapeutics
- Medtronic
- Verily Life Sciences
- Larimar Therapeutics
- Senseonics
- Bigfoot Biomedical
- What is the 10-year outlook for the global Non-injectable Insulin market?
- What factors are driving Non-injectable Insulin market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Non-injectable Insulin market opportunities vary by end market size?
- How does Non-injectable Insulin break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Non-injectable Insulin Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Non-injectable Insulin by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Non-injectable Insulin by Country/Region, 2021, 2025 & 2032
2.2 Non-injectable Insulin Segment by Type
2.2.1 Oral Pills
2.2.2 Sprays
2.2.3 Others
2.2.4 Non-injectable Insulin Sales by Type
2.2.4.1 Global Non-injectable Insulin Sales Market Share by Type (2021-2026)
2.2.4.2 Global Non-injectable Insulin Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Non-injectable Insulin Sale Price by Type (2021-2026)
2.3 Non-injectable Insulin Segment by Application
2.3.1 T1DM
2.3.2 T2DM
2.3.3 Non-injectable Insulin Sales by Application
2.3.3.1 Global Non-injectable Insulin Sale Market Share by Application (2021-2026)
2.3.3.2 Global Non-injectable Insulin Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Non-injectable Insulin Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Non-injectable Insulin Breakdown Data by Company
3.1.1 Global Non-injectable Insulin Annual Sales by Company (2021-2026)
3.1.2 Global Non-injectable Insulin Sales Market Share by Company (2021-2026)
3.2 Global Non-injectable Insulin Annual Revenue by Company (2021-2026)
3.2.1 Global Non-injectable Insulin Revenue by Company (2021-2026)
3.2.2 Global Non-injectable Insulin Revenue Market Share by Company (2021-2026)
3.3 Global Non-injectable Insulin Sale Price by Company
3.4 Key Manufacturers Non-injectable Insulin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Non-injectable Insulin Product Location Distribution
3.4.2 Players Non-injectable Insulin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NON-INJECTABLE INSULIN BY GEOGRAPHIC REGION
4.1 World Historic Non-injectable Insulin Market Size by Geographic Region (2021-2026)
4.1.1 Global Non-injectable Insulin Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Non-injectable Insulin Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Non-injectable Insulin Market Size by Country/Region (2021-2026)
4.2.1 Global Non-injectable Insulin Annual Sales by Country/Region (2021-2026)
4.2.2 Global Non-injectable Insulin Annual Revenue by Country/Region (2021-2026)
4.3 Americas Non-injectable Insulin Sales Growth
4.4 APAC Non-injectable Insulin Sales Growth
4.5 Europe Non-injectable Insulin Sales Growth
4.6 Middle East & Africa Non-injectable Insulin Sales Growth
5 AMERICAS
5.1 Americas Non-injectable Insulin Sales by Country
5.1.1 Americas Non-injectable Insulin Sales by Country (2021-2026)
5.1.2 Americas Non-injectable Insulin Revenue by Country (2021-2026)
5.2 Americas Non-injectable Insulin Sales by Type (2021-2026)
5.3 Americas Non-injectable Insulin Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-injectable Insulin Sales by Region
6.1.1 APAC Non-injectable Insulin Sales by Region (2021-2026)
6.1.2 APAC Non-injectable Insulin Revenue by Region (2021-2026)
6.2 APAC Non-injectable Insulin Sales by Type (2021-2026)
6.3 APAC Non-injectable Insulin Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Non-injectable Insulin by Country
7.1.1 Europe Non-injectable Insulin Sales by Country (2021-2026)
7.1.2 Europe Non-injectable Insulin Revenue by Country (2021-2026)
7.2 Europe Non-injectable Insulin Sales by Type (2021-2026)
7.3 Europe Non-injectable Insulin Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Non-injectable Insulin by Country
8.1.1 Middle East & Africa Non-injectable Insulin Sales by Country (2021-2026)
8.1.2 Middle East & Africa Non-injectable Insulin Revenue by Country (2021-2026)
8.2 Middle East & Africa Non-injectable Insulin Sales by Type (2021-2026)
8.3 Middle East & Africa Non-injectable Insulin Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Non-injectable Insulin
10.3 Manufacturing Process Analysis of Non-injectable Insulin
10.4 Industry Chain Structure of Non-injectable Insulin
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Non-injectable Insulin Distributors
11.3 Non-injectable Insulin Customer
12 WORLD FORECAST REVIEW FOR NON-INJECTABLE INSULIN BY GEOGRAPHIC REGION
12.1 Global Non-injectable Insulin Market Size Forecast by Region
12.1.1 Global Non-injectable Insulin Forecast by Region (2027-2032)
12.1.2 Global Non-injectable Insulin Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Non-injectable Insulin Forecast by Type (2027-2032)
12.7 Global Non-injectable Insulin Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk Non-injectable Insulin Product Portfolios and Specifications
13.1.3 Novo Nordisk Non-injectable Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Non-injectable Insulin Product Portfolios and Specifications
13.2.3 Sanofi Non-injectable Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 Eli Lilly
13.3.1 Eli Lilly Company Information
13.3.2 Eli Lilly Non-injectable Insulin Product Portfolios and Specifications
13.3.3 Eli Lilly Non-injectable Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Eli Lilly Main Business Overview
13.3.5 Eli Lilly Latest Developments
13.4 MannKind Corporation
13.4.1 MannKind Corporation Company Information
13.4.2 MannKind Corporation Non-injectable Insulin Product Portfolios and Specifications
13.4.3 MannKind Corporation Non-injectable Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 MannKind Corporation Main Business Overview
13.4.5 MannKind Corporation Latest Developments
13.5 Biocon
13.5.1 Biocon Company Information
13.5.2 Biocon Non-injectable Insulin Product Portfolios and Specifications
13.5.3 Biocon Non-injectable Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Biocon Main Business Overview
13.5.5 Biocon Latest Developments
13.6 Janssen Pharmaceuticals
13.6.1 Janssen Pharmaceuticals Company Information
13.6.2 Janssen Pharmaceuticals Non-injectable Insulin Product Portfolios and Specifications
13.6.3 Janssen Pharmaceuticals Non-injectable Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Janssen Pharmaceuticals Main Business Overview
13.6.5 Janssen Pharmaceuticals Latest Developments
13.7 Adocia
13.7.1 Adocia Company Information
13.7.2 Adocia Non-injectable Insulin Product Portfolios and Specifications
13.7.3 Adocia Non-injectable Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Adocia Main Business Overview
13.7.5 Adocia Latest Developments
13.8 Oramed Pharmaceuticals
13.8.1 Oramed Pharmaceuticals Company Information
13.8.2 Oramed Pharmaceuticals Non-injectable Insulin Product Portfolios and Specifications
13.8.3 Oramed Pharmaceuticals Non-injectable Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Oramed Pharmaceuticals Main Business Overview
13.8.5 Oramed Pharmaceuticals Latest Developments
13.9 Aerami Therapeutics
13.9.1 Aerami Therapeutics Company Information
13.9.2 Aerami Therapeutics Non-injectable Insulin Product Portfolios and Specifications
13.9.3 Aerami Therapeutics Non-injectable Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Aerami Therapeutics Main Business Overview
13.9.5 Aerami Therapeutics Latest Developments
13.10 Medtronic
13.10.1 Medtronic Company Information
13.10.2 Medtronic Non-injectable Insulin Product Portfolios and Specifications
13.10.3 Medtronic Non-injectable Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Medtronic Main Business Overview
13.10.5 Medtronic Latest Developments
13.11 Verily Life Sciences
13.11.1 Verily Life Sciences Company Information
13.11.2 Verily Life Sciences Non-injectable Insulin Product Portfolios and Specifications
13.11.3 Verily Life Sciences Non-injectable Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Verily Life Sciences Main Business Overview
13.11.5 Verily Life Sciences Latest Developments
13.12 Larimar Therapeutics
13.12.1 Larimar Therapeutics Company Information
13.12.2 Larimar Therapeutics Non-injectable Insulin Product Portfolios and Specifications
13.12.3 Larimar Therapeutics Non-injectable Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Larimar Therapeutics Main Business Overview
13.12.5 Larimar Therapeutics Latest Developments
13.13 Senseonics
13.13.1 Senseonics Company Information
13.13.2 Senseonics Non-injectable Insulin Product Portfolios and Specifications
13.13.3 Senseonics Non-injectable Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Senseonics Main Business Overview
13.13.5 Senseonics Latest Developments
13.14 Bigfoot Biomedical
13.14.1 Bigfoot Biomedical Company Information
13.14.2 Bigfoot Biomedical Non-injectable Insulin Product Portfolios and Specifications
13.14.3 Bigfoot Biomedical Non-injectable Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Bigfoot Biomedical Main Business Overview
13.14.5 Bigfoot Biomedical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Non-injectable Insulin Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Non-injectable Insulin by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Non-injectable Insulin by Country/Region, 2021, 2025 & 2032
2.2 Non-injectable Insulin Segment by Type
2.2.1 Oral Pills
2.2.2 Sprays
2.2.3 Others
2.2.4 Non-injectable Insulin Sales by Type
2.2.4.1 Global Non-injectable Insulin Sales Market Share by Type (2021-2026)
2.2.4.2 Global Non-injectable Insulin Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Non-injectable Insulin Sale Price by Type (2021-2026)
2.3 Non-injectable Insulin Segment by Application
2.3.1 T1DM
2.3.2 T2DM
2.3.3 Non-injectable Insulin Sales by Application
2.3.3.1 Global Non-injectable Insulin Sale Market Share by Application (2021-2026)
2.3.3.2 Global Non-injectable Insulin Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Non-injectable Insulin Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Non-injectable Insulin Breakdown Data by Company
3.1.1 Global Non-injectable Insulin Annual Sales by Company (2021-2026)
3.1.2 Global Non-injectable Insulin Sales Market Share by Company (2021-2026)
3.2 Global Non-injectable Insulin Annual Revenue by Company (2021-2026)
3.2.1 Global Non-injectable Insulin Revenue by Company (2021-2026)
3.2.2 Global Non-injectable Insulin Revenue Market Share by Company (2021-2026)
3.3 Global Non-injectable Insulin Sale Price by Company
3.4 Key Manufacturers Non-injectable Insulin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Non-injectable Insulin Product Location Distribution
3.4.2 Players Non-injectable Insulin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NON-INJECTABLE INSULIN BY GEOGRAPHIC REGION
4.1 World Historic Non-injectable Insulin Market Size by Geographic Region (2021-2026)
4.1.1 Global Non-injectable Insulin Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Non-injectable Insulin Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Non-injectable Insulin Market Size by Country/Region (2021-2026)
4.2.1 Global Non-injectable Insulin Annual Sales by Country/Region (2021-2026)
4.2.2 Global Non-injectable Insulin Annual Revenue by Country/Region (2021-2026)
4.3 Americas Non-injectable Insulin Sales Growth
4.4 APAC Non-injectable Insulin Sales Growth
4.5 Europe Non-injectable Insulin Sales Growth
4.6 Middle East & Africa Non-injectable Insulin Sales Growth
5 AMERICAS
5.1 Americas Non-injectable Insulin Sales by Country
5.1.1 Americas Non-injectable Insulin Sales by Country (2021-2026)
5.1.2 Americas Non-injectable Insulin Revenue by Country (2021-2026)
5.2 Americas Non-injectable Insulin Sales by Type (2021-2026)
5.3 Americas Non-injectable Insulin Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-injectable Insulin Sales by Region
6.1.1 APAC Non-injectable Insulin Sales by Region (2021-2026)
6.1.2 APAC Non-injectable Insulin Revenue by Region (2021-2026)
6.2 APAC Non-injectable Insulin Sales by Type (2021-2026)
6.3 APAC Non-injectable Insulin Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Non-injectable Insulin by Country
7.1.1 Europe Non-injectable Insulin Sales by Country (2021-2026)
7.1.2 Europe Non-injectable Insulin Revenue by Country (2021-2026)
7.2 Europe Non-injectable Insulin Sales by Type (2021-2026)
7.3 Europe Non-injectable Insulin Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Non-injectable Insulin by Country
8.1.1 Middle East & Africa Non-injectable Insulin Sales by Country (2021-2026)
8.1.2 Middle East & Africa Non-injectable Insulin Revenue by Country (2021-2026)
8.2 Middle East & Africa Non-injectable Insulin Sales by Type (2021-2026)
8.3 Middle East & Africa Non-injectable Insulin Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Non-injectable Insulin
10.3 Manufacturing Process Analysis of Non-injectable Insulin
10.4 Industry Chain Structure of Non-injectable Insulin
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Non-injectable Insulin Distributors
11.3 Non-injectable Insulin Customer
12 WORLD FORECAST REVIEW FOR NON-INJECTABLE INSULIN BY GEOGRAPHIC REGION
12.1 Global Non-injectable Insulin Market Size Forecast by Region
12.1.1 Global Non-injectable Insulin Forecast by Region (2027-2032)
12.1.2 Global Non-injectable Insulin Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Non-injectable Insulin Forecast by Type (2027-2032)
12.7 Global Non-injectable Insulin Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk Non-injectable Insulin Product Portfolios and Specifications
13.1.3 Novo Nordisk Non-injectable Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Non-injectable Insulin Product Portfolios and Specifications
13.2.3 Sanofi Non-injectable Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 Eli Lilly
13.3.1 Eli Lilly Company Information
13.3.2 Eli Lilly Non-injectable Insulin Product Portfolios and Specifications
13.3.3 Eli Lilly Non-injectable Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Eli Lilly Main Business Overview
13.3.5 Eli Lilly Latest Developments
13.4 MannKind Corporation
13.4.1 MannKind Corporation Company Information
13.4.2 MannKind Corporation Non-injectable Insulin Product Portfolios and Specifications
13.4.3 MannKind Corporation Non-injectable Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 MannKind Corporation Main Business Overview
13.4.5 MannKind Corporation Latest Developments
13.5 Biocon
13.5.1 Biocon Company Information
13.5.2 Biocon Non-injectable Insulin Product Portfolios and Specifications
13.5.3 Biocon Non-injectable Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Biocon Main Business Overview
13.5.5 Biocon Latest Developments
13.6 Janssen Pharmaceuticals
13.6.1 Janssen Pharmaceuticals Company Information
13.6.2 Janssen Pharmaceuticals Non-injectable Insulin Product Portfolios and Specifications
13.6.3 Janssen Pharmaceuticals Non-injectable Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Janssen Pharmaceuticals Main Business Overview
13.6.5 Janssen Pharmaceuticals Latest Developments
13.7 Adocia
13.7.1 Adocia Company Information
13.7.2 Adocia Non-injectable Insulin Product Portfolios and Specifications
13.7.3 Adocia Non-injectable Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Adocia Main Business Overview
13.7.5 Adocia Latest Developments
13.8 Oramed Pharmaceuticals
13.8.1 Oramed Pharmaceuticals Company Information
13.8.2 Oramed Pharmaceuticals Non-injectable Insulin Product Portfolios and Specifications
13.8.3 Oramed Pharmaceuticals Non-injectable Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Oramed Pharmaceuticals Main Business Overview
13.8.5 Oramed Pharmaceuticals Latest Developments
13.9 Aerami Therapeutics
13.9.1 Aerami Therapeutics Company Information
13.9.2 Aerami Therapeutics Non-injectable Insulin Product Portfolios and Specifications
13.9.3 Aerami Therapeutics Non-injectable Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Aerami Therapeutics Main Business Overview
13.9.5 Aerami Therapeutics Latest Developments
13.10 Medtronic
13.10.1 Medtronic Company Information
13.10.2 Medtronic Non-injectable Insulin Product Portfolios and Specifications
13.10.3 Medtronic Non-injectable Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Medtronic Main Business Overview
13.10.5 Medtronic Latest Developments
13.11 Verily Life Sciences
13.11.1 Verily Life Sciences Company Information
13.11.2 Verily Life Sciences Non-injectable Insulin Product Portfolios and Specifications
13.11.3 Verily Life Sciences Non-injectable Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Verily Life Sciences Main Business Overview
13.11.5 Verily Life Sciences Latest Developments
13.12 Larimar Therapeutics
13.12.1 Larimar Therapeutics Company Information
13.12.2 Larimar Therapeutics Non-injectable Insulin Product Portfolios and Specifications
13.12.3 Larimar Therapeutics Non-injectable Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Larimar Therapeutics Main Business Overview
13.12.5 Larimar Therapeutics Latest Developments
13.13 Senseonics
13.13.1 Senseonics Company Information
13.13.2 Senseonics Non-injectable Insulin Product Portfolios and Specifications
13.13.3 Senseonics Non-injectable Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Senseonics Main Business Overview
13.13.5 Senseonics Latest Developments
13.14 Bigfoot Biomedical
13.14.1 Bigfoot Biomedical Company Information
13.14.2 Bigfoot Biomedical Non-injectable Insulin Product Portfolios and Specifications
13.14.3 Bigfoot Biomedical Non-injectable Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Bigfoot Biomedical Main Business Overview
13.14.5 Bigfoot Biomedical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Non-injectable Insulin Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Non-injectable Insulin Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Oral Pills
Table 4. Major Players of Sprays
Table 5. Major Players of Others
Table 6. Global Non-injectable Insulin Sales by Type (2021-2026) & (Units)
Table 7. Global Non-injectable Insulin Sales Market Share by Type (2021-2026)
Table 8. Global Non-injectable Insulin Revenue by Type (2021-2026) & ($ million)
Table 9. Global Non-injectable Insulin Revenue Market Share by Type (2021-2026)
Table 10. Global Non-injectable Insulin Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Non-injectable Insulin Sale by Application (2021-2026) & (Units)
Table 12. Global Non-injectable Insulin Sale Market Share by Application (2021-2026)
Table 13. Global Non-injectable Insulin Revenue by Application (2021-2026) & ($ million)
Table 14. Global Non-injectable Insulin Revenue Market Share by Application (2021-2026)
Table 15. Global Non-injectable Insulin Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Non-injectable Insulin Sales by Company (2021-2026) & (Units)
Table 17. Global Non-injectable Insulin Sales Market Share by Company (2021-2026)
Table 18. Global Non-injectable Insulin Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Non-injectable Insulin Revenue Market Share by Company (2021-2026)
Table 20. Global Non-injectable Insulin Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Non-injectable Insulin Producing Area Distribution and Sales Area
Table 22. Players Non-injectable Insulin Products Offered
Table 23. Non-injectable Insulin Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Non-injectable Insulin Sales by Geographic Region (2021-2026) & (Units)
Table 27. Global Non-injectable Insulin Sales Market Share Geographic Region (2021-2026)
Table 28. Global Non-injectable Insulin Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Non-injectable Insulin Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Non-injectable Insulin Sales by Country/Region (2021-2026) & (Units)
Table 31. Global Non-injectable Insulin Sales Market Share by Country/Region (2021-2026)
Table 32. Global Non-injectable Insulin Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Non-injectable Insulin Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Non-injectable Insulin Sales by Country (2021-2026) & (Units)
Table 35. Americas Non-injectable Insulin Sales Market Share by Country (2021-2026)
Table 36. Americas Non-injectable Insulin Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Non-injectable Insulin Sales by Type (2021-2026) & (Units)
Table 38. Americas Non-injectable Insulin Sales by Application (2021-2026) & (Units)
Table 39. APAC Non-injectable Insulin Sales by Region (2021-2026) & (Units)
Table 40. APAC Non-injectable Insulin Sales Market Share by Region (2021-2026)
Table 41. APAC Non-injectable Insulin Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Non-injectable Insulin Sales by Type (2021-2026) & (Units)
Table 43. APAC Non-injectable Insulin Sales by Application (2021-2026) & (Units)
Table 44. Europe Non-injectable Insulin Sales by Country (2021-2026) & (Units)
Table 45. Europe Non-injectable Insulin Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Non-injectable Insulin Sales by Type (2021-2026) & (Units)
Table 47. Europe Non-injectable Insulin Sales by Application (2021-2026) & (Units)
Table 48. Middle East & Africa Non-injectable Insulin Sales by Country (2021-2026) & (Units)
Table 49. Middle East & Africa Non-injectable Insulin Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Non-injectable Insulin Sales by Type (2021-2026) & (Units)
Table 51. Middle East & Africa Non-injectable Insulin Sales by Application (2021-2026) & (Units)
Table 52. Key Market Drivers & Growth Opportunities of Non-injectable Insulin
Table 53. Key Market Challenges & Risks of Non-injectable Insulin
Table 54. Key Industry Trends of Non-injectable Insulin
Table 55. Non-injectable Insulin Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Non-injectable Insulin Distributors List
Table 58. Non-injectable Insulin Customer List
Table 59. Global Non-injectable Insulin Sales Forecast by Region (2027-2032) & (Units)
Table 60. Global Non-injectable Insulin Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Non-injectable Insulin Sales Forecast by Country (2027-2032) & (Units)
Table 62. Americas Non-injectable Insulin Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Non-injectable Insulin Sales Forecast by Region (2027-2032) & (Units)
Table 64. APAC Non-injectable Insulin Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Non-injectable Insulin Sales Forecast by Country (2027-2032) & (Units)
Table 66. Europe Non-injectable Insulin Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Non-injectable Insulin Sales Forecast by Country (2027-2032) & (Units)
Table 68. Middle East & Africa Non-injectable Insulin Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Non-injectable Insulin Sales Forecast by Type (2027-2032) & (Units)
Table 70. Global Non-injectable Insulin Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Non-injectable Insulin Sales Forecast by Application (2027-2032) & (Units)
Table 72. Global Non-injectable Insulin Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Novo Nordisk Basic Information, Non-injectable Insulin Manufacturing Base, Sales Area and Its Competitors
Table 74. Novo Nordisk Non-injectable Insulin Product Portfolios and Specifications
Table 75. Novo Nordisk Non-injectable Insulin Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Novo Nordisk Main Business
Table 77. Novo Nordisk Latest Developments
Table 78. Sanofi Basic Information, Non-injectable Insulin Manufacturing Base, Sales Area and Its Competitors
Table 79. Sanofi Non-injectable Insulin Product Portfolios and Specifications
Table 80. Sanofi Non-injectable Insulin Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Sanofi Main Business
Table 82. Sanofi Latest Developments
Table 83. Eli Lilly Basic Information, Non-injectable Insulin Manufacturing Base, Sales Area and Its Competitors
Table 84. Eli Lilly Non-injectable Insulin Product Portfolios and Specifications
Table 85. Eli Lilly Non-injectable Insulin Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Eli Lilly Main Business
Table 87. Eli Lilly Latest Developments
Table 88. MannKind Corporation Basic Information, Non-injectable Insulin Manufacturing Base, Sales Area and Its Competitors
Table 89. MannKind Corporation Non-injectable Insulin Product Portfolios and Specifications
Table 90. MannKind Corporation Non-injectable Insulin Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. MannKind Corporation Main Business
Table 92. MannKind Corporation Latest Developments
Table 93. Biocon Basic Information, Non-injectable Insulin Manufacturing Base, Sales Area and Its Competitors
Table 94. Biocon Non-injectable Insulin Product Portfolios and Specifications
Table 95. Biocon Non-injectable Insulin Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Biocon Main Business
Table 97. Biocon Latest Developments
Table 98. Janssen Pharmaceuticals Basic Information, Non-injectable Insulin Manufacturing Base, Sales Area and Its Competitors
Table 99. Janssen Pharmaceuticals Non-injectable Insulin Product Portfolios and Specifications
Table 100. Janssen Pharmaceuticals Non-injectable Insulin Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Janssen Pharmaceuticals Main Business
Table 102. Janssen Pharmaceuticals Latest Developments
Table 103. Adocia Basic Information, Non-injectable Insulin Manufacturing Base, Sales Area and Its Competitors
Table 104. Adocia Non-injectable Insulin Product Portfolios and Specifications
Table 105. Adocia Non-injectable Insulin Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Adocia Main Business
Table 107. Adocia Latest Developments
Table 108. Oramed Pharmaceuticals Basic Information, Non-injectable Insulin Manufacturing Base, Sales Area and Its Competitors
Table 109. Oramed Pharmaceuticals Non-injectable Insulin Product Portfolios and Specifications
Table 110. Oramed Pharmaceuticals Non-injectable Insulin Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Oramed Pharmaceuticals Main Business
Table 112. Oramed Pharmaceuticals Latest Developments
Table 113. Aerami Therapeutics Basic Information, Non-injectable Insulin Manufacturing Base, Sales Area and Its Competitors
Table 114. Aerami Therapeutics Non-injectable Insulin Product Portfolios and Specifications
Table 115. Aerami Therapeutics Non-injectable Insulin Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Aerami Therapeutics Main Business
Table 117. Aerami Therapeutics Latest Developments
Table 118. Medtronic Basic Information, Non-injectable Insulin Manufacturing Base, Sales Area and Its Competitors
Table 119. Medtronic Non-injectable Insulin Product Portfolios and Specifications
Table 120. Medtronic Non-injectable Insulin Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Medtronic Main Business
Table 122. Medtronic Latest Developments
Table 123. Verily Life Sciences Basic Information, Non-injectable Insulin Manufacturing Base, Sales Area and Its Competitors
Table 124. Verily Life Sciences Non-injectable Insulin Product Portfolios and Specifications
Table 125. Verily Life Sciences Non-injectable Insulin Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Verily Life Sciences Main Business
Table 127. Verily Life Sciences Latest Developments
Table 128. Larimar Therapeutics Basic Information, Non-injectable Insulin Manufacturing Base, Sales Area and Its Competitors
Table 129. Larimar Therapeutics Non-injectable Insulin Product Portfolios and Specifications
Table 130. Larimar Therapeutics Non-injectable Insulin Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Larimar Therapeutics Main Business
Table 132. Larimar Therapeutics Latest Developments
Table 133. Senseonics Basic Information, Non-injectable Insulin Manufacturing Base, Sales Area and Its Competitors
Table 134. Senseonics Non-injectable Insulin Product Portfolios and Specifications
Table 135. Senseonics Non-injectable Insulin Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. Senseonics Main Business
Table 137. Senseonics Latest Developments
Table 138. Bigfoot Biomedical Basic Information, Non-injectable Insulin Manufacturing Base, Sales Area and Its Competitors
Table 139. Bigfoot Biomedical Non-injectable Insulin Product Portfolios and Specifications
Table 140. Bigfoot Biomedical Non-injectable Insulin Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 141. Bigfoot Biomedical Main Business
Table 142. Bigfoot Biomedical Latest Developments
Table 1. Non-injectable Insulin Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Non-injectable Insulin Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Oral Pills
Table 4. Major Players of Sprays
Table 5. Major Players of Others
Table 6. Global Non-injectable Insulin Sales by Type (2021-2026) & (Units)
Table 7. Global Non-injectable Insulin Sales Market Share by Type (2021-2026)
Table 8. Global Non-injectable Insulin Revenue by Type (2021-2026) & ($ million)
Table 9. Global Non-injectable Insulin Revenue Market Share by Type (2021-2026)
Table 10. Global Non-injectable Insulin Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Non-injectable Insulin Sale by Application (2021-2026) & (Units)
Table 12. Global Non-injectable Insulin Sale Market Share by Application (2021-2026)
Table 13. Global Non-injectable Insulin Revenue by Application (2021-2026) & ($ million)
Table 14. Global Non-injectable Insulin Revenue Market Share by Application (2021-2026)
Table 15. Global Non-injectable Insulin Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Non-injectable Insulin Sales by Company (2021-2026) & (Units)
Table 17. Global Non-injectable Insulin Sales Market Share by Company (2021-2026)
Table 18. Global Non-injectable Insulin Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Non-injectable Insulin Revenue Market Share by Company (2021-2026)
Table 20. Global Non-injectable Insulin Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Non-injectable Insulin Producing Area Distribution and Sales Area
Table 22. Players Non-injectable Insulin Products Offered
Table 23. Non-injectable Insulin Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Non-injectable Insulin Sales by Geographic Region (2021-2026) & (Units)
Table 27. Global Non-injectable Insulin Sales Market Share Geographic Region (2021-2026)
Table 28. Global Non-injectable Insulin Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Non-injectable Insulin Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Non-injectable Insulin Sales by Country/Region (2021-2026) & (Units)
Table 31. Global Non-injectable Insulin Sales Market Share by Country/Region (2021-2026)
Table 32. Global Non-injectable Insulin Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Non-injectable Insulin Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Non-injectable Insulin Sales by Country (2021-2026) & (Units)
Table 35. Americas Non-injectable Insulin Sales Market Share by Country (2021-2026)
Table 36. Americas Non-injectable Insulin Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Non-injectable Insulin Sales by Type (2021-2026) & (Units)
Table 38. Americas Non-injectable Insulin Sales by Application (2021-2026) & (Units)
Table 39. APAC Non-injectable Insulin Sales by Region (2021-2026) & (Units)
Table 40. APAC Non-injectable Insulin Sales Market Share by Region (2021-2026)
Table 41. APAC Non-injectable Insulin Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Non-injectable Insulin Sales by Type (2021-2026) & (Units)
Table 43. APAC Non-injectable Insulin Sales by Application (2021-2026) & (Units)
Table 44. Europe Non-injectable Insulin Sales by Country (2021-2026) & (Units)
Table 45. Europe Non-injectable Insulin Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Non-injectable Insulin Sales by Type (2021-2026) & (Units)
Table 47. Europe Non-injectable Insulin Sales by Application (2021-2026) & (Units)
Table 48. Middle East & Africa Non-injectable Insulin Sales by Country (2021-2026) & (Units)
Table 49. Middle East & Africa Non-injectable Insulin Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Non-injectable Insulin Sales by Type (2021-2026) & (Units)
Table 51. Middle East & Africa Non-injectable Insulin Sales by Application (2021-2026) & (Units)
Table 52. Key Market Drivers & Growth Opportunities of Non-injectable Insulin
Table 53. Key Market Challenges & Risks of Non-injectable Insulin
Table 54. Key Industry Trends of Non-injectable Insulin
Table 55. Non-injectable Insulin Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Non-injectable Insulin Distributors List
Table 58. Non-injectable Insulin Customer List
Table 59. Global Non-injectable Insulin Sales Forecast by Region (2027-2032) & (Units)
Table 60. Global Non-injectable Insulin Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Non-injectable Insulin Sales Forecast by Country (2027-2032) & (Units)
Table 62. Americas Non-injectable Insulin Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Non-injectable Insulin Sales Forecast by Region (2027-2032) & (Units)
Table 64. APAC Non-injectable Insulin Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Non-injectable Insulin Sales Forecast by Country (2027-2032) & (Units)
Table 66. Europe Non-injectable Insulin Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Non-injectable Insulin Sales Forecast by Country (2027-2032) & (Units)
Table 68. Middle East & Africa Non-injectable Insulin Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Non-injectable Insulin Sales Forecast by Type (2027-2032) & (Units)
Table 70. Global Non-injectable Insulin Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Non-injectable Insulin Sales Forecast by Application (2027-2032) & (Units)
Table 72. Global Non-injectable Insulin Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Novo Nordisk Basic Information, Non-injectable Insulin Manufacturing Base, Sales Area and Its Competitors
Table 74. Novo Nordisk Non-injectable Insulin Product Portfolios and Specifications
Table 75. Novo Nordisk Non-injectable Insulin Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Novo Nordisk Main Business
Table 77. Novo Nordisk Latest Developments
Table 78. Sanofi Basic Information, Non-injectable Insulin Manufacturing Base, Sales Area and Its Competitors
Table 79. Sanofi Non-injectable Insulin Product Portfolios and Specifications
Table 80. Sanofi Non-injectable Insulin Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Sanofi Main Business
Table 82. Sanofi Latest Developments
Table 83. Eli Lilly Basic Information, Non-injectable Insulin Manufacturing Base, Sales Area and Its Competitors
Table 84. Eli Lilly Non-injectable Insulin Product Portfolios and Specifications
Table 85. Eli Lilly Non-injectable Insulin Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Eli Lilly Main Business
Table 87. Eli Lilly Latest Developments
Table 88. MannKind Corporation Basic Information, Non-injectable Insulin Manufacturing Base, Sales Area and Its Competitors
Table 89. MannKind Corporation Non-injectable Insulin Product Portfolios and Specifications
Table 90. MannKind Corporation Non-injectable Insulin Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. MannKind Corporation Main Business
Table 92. MannKind Corporation Latest Developments
Table 93. Biocon Basic Information, Non-injectable Insulin Manufacturing Base, Sales Area and Its Competitors
Table 94. Biocon Non-injectable Insulin Product Portfolios and Specifications
Table 95. Biocon Non-injectable Insulin Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Biocon Main Business
Table 97. Biocon Latest Developments
Table 98. Janssen Pharmaceuticals Basic Information, Non-injectable Insulin Manufacturing Base, Sales Area and Its Competitors
Table 99. Janssen Pharmaceuticals Non-injectable Insulin Product Portfolios and Specifications
Table 100. Janssen Pharmaceuticals Non-injectable Insulin Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Janssen Pharmaceuticals Main Business
Table 102. Janssen Pharmaceuticals Latest Developments
Table 103. Adocia Basic Information, Non-injectable Insulin Manufacturing Base, Sales Area and Its Competitors
Table 104. Adocia Non-injectable Insulin Product Portfolios and Specifications
Table 105. Adocia Non-injectable Insulin Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Adocia Main Business
Table 107. Adocia Latest Developments
Table 108. Oramed Pharmaceuticals Basic Information, Non-injectable Insulin Manufacturing Base, Sales Area and Its Competitors
Table 109. Oramed Pharmaceuticals Non-injectable Insulin Product Portfolios and Specifications
Table 110. Oramed Pharmaceuticals Non-injectable Insulin Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Oramed Pharmaceuticals Main Business
Table 112. Oramed Pharmaceuticals Latest Developments
Table 113. Aerami Therapeutics Basic Information, Non-injectable Insulin Manufacturing Base, Sales Area and Its Competitors
Table 114. Aerami Therapeutics Non-injectable Insulin Product Portfolios and Specifications
Table 115. Aerami Therapeutics Non-injectable Insulin Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Aerami Therapeutics Main Business
Table 117. Aerami Therapeutics Latest Developments
Table 118. Medtronic Basic Information, Non-injectable Insulin Manufacturing Base, Sales Area and Its Competitors
Table 119. Medtronic Non-injectable Insulin Product Portfolios and Specifications
Table 120. Medtronic Non-injectable Insulin Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Medtronic Main Business
Table 122. Medtronic Latest Developments
Table 123. Verily Life Sciences Basic Information, Non-injectable Insulin Manufacturing Base, Sales Area and Its Competitors
Table 124. Verily Life Sciences Non-injectable Insulin Product Portfolios and Specifications
Table 125. Verily Life Sciences Non-injectable Insulin Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Verily Life Sciences Main Business
Table 127. Verily Life Sciences Latest Developments
Table 128. Larimar Therapeutics Basic Information, Non-injectable Insulin Manufacturing Base, Sales Area and Its Competitors
Table 129. Larimar Therapeutics Non-injectable Insulin Product Portfolios and Specifications
Table 130. Larimar Therapeutics Non-injectable Insulin Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Larimar Therapeutics Main Business
Table 132. Larimar Therapeutics Latest Developments
Table 133. Senseonics Basic Information, Non-injectable Insulin Manufacturing Base, Sales Area and Its Competitors
Table 134. Senseonics Non-injectable Insulin Product Portfolios and Specifications
Table 135. Senseonics Non-injectable Insulin Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. Senseonics Main Business
Table 137. Senseonics Latest Developments
Table 138. Bigfoot Biomedical Basic Information, Non-injectable Insulin Manufacturing Base, Sales Area and Its Competitors
Table 139. Bigfoot Biomedical Non-injectable Insulin Product Portfolios and Specifications
Table 140. Bigfoot Biomedical Non-injectable Insulin Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 141. Bigfoot Biomedical Main Business
Table 142. Bigfoot Biomedical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Non-injectable Insulin
Figure 2. Non-injectable Insulin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Non-injectable Insulin Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Non-injectable Insulin Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Non-injectable Insulin Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Non-injectable Insulin Sales Market Share by Country/Region (2025)
Figure 10. Non-injectable Insulin Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Oral Pills
Figure 12. Product Picture of Sprays
Figure 13. Product Picture of Others
Figure 14. Global Non-injectable Insulin Sales Market Share by Type in 2026
Figure 15. Global Non-injectable Insulin Revenue Market Share by Type (2021-2026)
Figure 16. Non-injectable Insulin Consumed in T1DM
Figure 17. Global Non-injectable Insulin Market: T1DM (2021-2026) & (Units)
Figure 18. Non-injectable Insulin Consumed in T2DM
Figure 19. Global Non-injectable Insulin Market: T2DM (2021-2026) & (Units)
Figure 20. Global Non-injectable Insulin Sale Market Share by Application (2025)
Figure 21. Global Non-injectable Insulin Revenue Market Share by Application in 2026
Figure 22. Non-injectable Insulin Sales by Company in 2026 (Units)
Figure 23. Global Non-injectable Insulin Sales Market Share by Company in 2026
Figure 24. Non-injectable Insulin Revenue by Company in 2026 ($ millions)
Figure 25. Global Non-injectable Insulin Revenue Market Share by Company in 2026
Figure 26. Global Non-injectable Insulin Sales Market Share by Geographic Region (2021-2026)
Figure 27. Global Non-injectable Insulin Revenue Market Share by Geographic Region in 2026
Figure 28. Americas Non-injectable Insulin Sales 2021-2026 (Units)
Figure 29. Americas Non-injectable Insulin Revenue 2021-2026 ($ millions)
Figure 30. APAC Non-injectable Insulin Sales 2021-2026 (Units)
Figure 31. APAC Non-injectable Insulin Revenue 2021-2026 ($ millions)
Figure 32. Europe Non-injectable Insulin Sales 2021-2026 (Units)
Figure 33. Europe Non-injectable Insulin Revenue 2021-2026 ($ millions)
Figure 34. Middle East & Africa Non-injectable Insulin Sales 2021-2026 (Units)
Figure 35. Middle East & Africa Non-injectable Insulin Revenue 2021-2026 ($ millions)
Figure 36. Americas Non-injectable Insulin Sales Market Share by Country in 2026
Figure 37. Americas Non-injectable Insulin Revenue Market Share by Country (2021-2026)
Figure 38. Americas Non-injectable Insulin Sales Market Share by Type (2021-2026)
Figure 39. Americas Non-injectable Insulin Sales Market Share by Application (2021-2026)
Figure 40. United States Non-injectable Insulin Revenue Growth 2021-2026 ($ millions)
Figure 41. Canada Non-injectable Insulin Revenue Growth 2021-2026 ($ millions)
Figure 42. Mexico Non-injectable Insulin Revenue Growth 2021-2026 ($ millions)
Figure 43. Brazil Non-injectable Insulin Revenue Growth 2021-2026 ($ millions)
Figure 44. APAC Non-injectable Insulin Sales Market Share by Region in 2026
Figure 45. APAC Non-injectable Insulin Revenue Market Share by Region (2021-2026)
Figure 46. APAC Non-injectable Insulin Sales Market Share by Type (2021-2026)
Figure 47. APAC Non-injectable Insulin Sales Market Share by Application (2021-2026)
Figure 48. China Non-injectable Insulin Revenue Growth 2021-2026 ($ millions)
Figure 49. Japan Non-injectable Insulin Revenue Growth 2021-2026 ($ millions)
Figure 50. South Korea Non-injectable Insulin Revenue Growth 2021-2026 ($ millions)
Figure 51. Southeast Asia Non-injectable Insulin Revenue Growth 2021-2026 ($ millions)
Figure 52. India Non-injectable Insulin Revenue Growth 2021-2026 ($ millions)
Figure 53. Australia Non-injectable Insulin Revenue Growth 2021-2026 ($ millions)
Figure 54. China Taiwan Non-injectable Insulin Revenue Growth 2021-2026 ($ millions)
Figure 55. Europe Non-injectable Insulin Sales Market Share by Country in 2026
Figure 56. Europe Non-injectable Insulin Revenue Market Share by Country (2021-2026)
Figure 57. Europe Non-injectable Insulin Sales Market Share by Type (2021-2026)
Figure 58. Europe Non-injectable Insulin Sales Market Share by Application (2021-2026)
Figure 59. Germany Non-injectable Insulin Revenue Growth 2021-2026 ($ millions)
Figure 60. France Non-injectable Insulin Revenue Growth 2021-2026 ($ millions)
Figure 61. UK Non-injectable Insulin Revenue Growth 2021-2026 ($ millions)
Figure 62. Italy Non-injectable Insulin Revenue Growth 2021-2026 ($ millions)
Figure 63. Russia Non-injectable Insulin Revenue Growth 2021-2026 ($ millions)
Figure 64. Middle East & Africa Non-injectable Insulin Sales Market Share by Country (2021-2026)
Figure 65. Middle East & Africa Non-injectable Insulin Sales Market Share by Type (2021-2026)
Figure 66. Middle East & Africa Non-injectable Insulin Sales Market Share by Application (2021-2026)
Figure 67. Egypt Non-injectable Insulin Revenue Growth 2021-2026 ($ millions)
Figure 68. South Africa Non-injectable Insulin Revenue Growth 2021-2026 ($ millions)
Figure 69. Israel Non-injectable Insulin Revenue Growth 2021-2026 ($ millions)
Figure 70. Turkey Non-injectable Insulin Revenue Growth 2021-2026 ($ millions)
Figure 71. GCC Countries Non-injectable Insulin Revenue Growth 2021-2026 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Non-injectable Insulin in 2026
Figure 73. Manufacturing Process Analysis of Non-injectable Insulin
Figure 74. Industry Chain Structure of Non-injectable Insulin
Figure 75. Channels of Distribution
Figure 76. Global Non-injectable Insulin Sales Market Forecast by Region (2027-2032)
Figure 77. Global Non-injectable Insulin Revenue Market Share Forecast by Region (2027-2032)
Figure 78. Global Non-injectable Insulin Sales Market Share Forecast by Type (2027-2032)
Figure 79. Global Non-injectable Insulin Revenue Market Share Forecast by Type (2027-2032)
Figure 80. Global Non-injectable Insulin Sales Market Share Forecast by Application (2027-2032)
Figure 81. Global Non-injectable Insulin Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Non-injectable Insulin
Figure 2. Non-injectable Insulin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Non-injectable Insulin Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Non-injectable Insulin Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Non-injectable Insulin Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Non-injectable Insulin Sales Market Share by Country/Region (2025)
Figure 10. Non-injectable Insulin Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Oral Pills
Figure 12. Product Picture of Sprays
Figure 13. Product Picture of Others
Figure 14. Global Non-injectable Insulin Sales Market Share by Type in 2026
Figure 15. Global Non-injectable Insulin Revenue Market Share by Type (2021-2026)
Figure 16. Non-injectable Insulin Consumed in T1DM
Figure 17. Global Non-injectable Insulin Market: T1DM (2021-2026) & (Units)
Figure 18. Non-injectable Insulin Consumed in T2DM
Figure 19. Global Non-injectable Insulin Market: T2DM (2021-2026) & (Units)
Figure 20. Global Non-injectable Insulin Sale Market Share by Application (2025)
Figure 21. Global Non-injectable Insulin Revenue Market Share by Application in 2026
Figure 22. Non-injectable Insulin Sales by Company in 2026 (Units)
Figure 23. Global Non-injectable Insulin Sales Market Share by Company in 2026
Figure 24. Non-injectable Insulin Revenue by Company in 2026 ($ millions)
Figure 25. Global Non-injectable Insulin Revenue Market Share by Company in 2026
Figure 26. Global Non-injectable Insulin Sales Market Share by Geographic Region (2021-2026)
Figure 27. Global Non-injectable Insulin Revenue Market Share by Geographic Region in 2026
Figure 28. Americas Non-injectable Insulin Sales 2021-2026 (Units)
Figure 29. Americas Non-injectable Insulin Revenue 2021-2026 ($ millions)
Figure 30. APAC Non-injectable Insulin Sales 2021-2026 (Units)
Figure 31. APAC Non-injectable Insulin Revenue 2021-2026 ($ millions)
Figure 32. Europe Non-injectable Insulin Sales 2021-2026 (Units)
Figure 33. Europe Non-injectable Insulin Revenue 2021-2026 ($ millions)
Figure 34. Middle East & Africa Non-injectable Insulin Sales 2021-2026 (Units)
Figure 35. Middle East & Africa Non-injectable Insulin Revenue 2021-2026 ($ millions)
Figure 36. Americas Non-injectable Insulin Sales Market Share by Country in 2026
Figure 37. Americas Non-injectable Insulin Revenue Market Share by Country (2021-2026)
Figure 38. Americas Non-injectable Insulin Sales Market Share by Type (2021-2026)
Figure 39. Americas Non-injectable Insulin Sales Market Share by Application (2021-2026)
Figure 40. United States Non-injectable Insulin Revenue Growth 2021-2026 ($ millions)
Figure 41. Canada Non-injectable Insulin Revenue Growth 2021-2026 ($ millions)
Figure 42. Mexico Non-injectable Insulin Revenue Growth 2021-2026 ($ millions)
Figure 43. Brazil Non-injectable Insulin Revenue Growth 2021-2026 ($ millions)
Figure 44. APAC Non-injectable Insulin Sales Market Share by Region in 2026
Figure 45. APAC Non-injectable Insulin Revenue Market Share by Region (2021-2026)
Figure 46. APAC Non-injectable Insulin Sales Market Share by Type (2021-2026)
Figure 47. APAC Non-injectable Insulin Sales Market Share by Application (2021-2026)
Figure 48. China Non-injectable Insulin Revenue Growth 2021-2026 ($ millions)
Figure 49. Japan Non-injectable Insulin Revenue Growth 2021-2026 ($ millions)
Figure 50. South Korea Non-injectable Insulin Revenue Growth 2021-2026 ($ millions)
Figure 51. Southeast Asia Non-injectable Insulin Revenue Growth 2021-2026 ($ millions)
Figure 52. India Non-injectable Insulin Revenue Growth 2021-2026 ($ millions)
Figure 53. Australia Non-injectable Insulin Revenue Growth 2021-2026 ($ millions)
Figure 54. China Taiwan Non-injectable Insulin Revenue Growth 2021-2026 ($ millions)
Figure 55. Europe Non-injectable Insulin Sales Market Share by Country in 2026
Figure 56. Europe Non-injectable Insulin Revenue Market Share by Country (2021-2026)
Figure 57. Europe Non-injectable Insulin Sales Market Share by Type (2021-2026)
Figure 58. Europe Non-injectable Insulin Sales Market Share by Application (2021-2026)
Figure 59. Germany Non-injectable Insulin Revenue Growth 2021-2026 ($ millions)
Figure 60. France Non-injectable Insulin Revenue Growth 2021-2026 ($ millions)
Figure 61. UK Non-injectable Insulin Revenue Growth 2021-2026 ($ millions)
Figure 62. Italy Non-injectable Insulin Revenue Growth 2021-2026 ($ millions)
Figure 63. Russia Non-injectable Insulin Revenue Growth 2021-2026 ($ millions)
Figure 64. Middle East & Africa Non-injectable Insulin Sales Market Share by Country (2021-2026)
Figure 65. Middle East & Africa Non-injectable Insulin Sales Market Share by Type (2021-2026)
Figure 66. Middle East & Africa Non-injectable Insulin Sales Market Share by Application (2021-2026)
Figure 67. Egypt Non-injectable Insulin Revenue Growth 2021-2026 ($ millions)
Figure 68. South Africa Non-injectable Insulin Revenue Growth 2021-2026 ($ millions)
Figure 69. Israel Non-injectable Insulin Revenue Growth 2021-2026 ($ millions)
Figure 70. Turkey Non-injectable Insulin Revenue Growth 2021-2026 ($ millions)
Figure 71. GCC Countries Non-injectable Insulin Revenue Growth 2021-2026 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Non-injectable Insulin in 2026
Figure 73. Manufacturing Process Analysis of Non-injectable Insulin
Figure 74. Industry Chain Structure of Non-injectable Insulin
Figure 75. Channels of Distribution
Figure 76. Global Non-injectable Insulin Sales Market Forecast by Region (2027-2032)
Figure 77. Global Non-injectable Insulin Revenue Market Share Forecast by Region (2027-2032)
Figure 78. Global Non-injectable Insulin Sales Market Share Forecast by Type (2027-2032)
Figure 79. Global Non-injectable Insulin Revenue Market Share Forecast by Type (2027-2032)
Figure 80. Global Non-injectable Insulin Sales Market Share Forecast by Application (2027-2032)
Figure 81. Global Non-injectable Insulin Revenue Market Share Forecast by Application (2027-2032)
